35 results about "Blood test result" patented technology

The present invention relates to methods and systems for providing an animal with a nutraceutical program that is specifically tailored to address the deficiencies and/or needs of the particular animal. Blood is drawn from the animal and analyzed at a lab to obtain blood test results. The blood test results are scored to obtain at least one blood test score for at least one corresponding blood parameter. If the at least one blood test score falls within a normal range but outside of an optimal range, one or more nutraceuticals needed to bring the animal within the optimal range for the at least one corresponding blood parameter are identified. A prescribed dosage amount is then calculated for at least one of the one or more identified nutraceuticals for the animal. The calculation of the prescribed dosage amount is based on at least the blood test score for the corresponding blood parameter and a deviation of the blood test score from the optimal range.

An image interpretation report creating apparatus for displaying a case in combination of an image interpretation report and a blood test result even if they are stored in different computers. The apparatus includes: a display unit for displaying an image interpretation report creation screen along with a blood test result; an input unit for specifying finding and a blood test result; a search key generating unit for generating search keys for searching an image interpretation report DB and a blood test result DB; a search processing unit for causing an image interpretation report server and an examination result server to obtain cases that match the search keys; a similarity degree determining unit for displaying the cases in an order of the degree of similarity; and an image interpretation report preservation unit for causing the image interpretation report server to store image interpretation report data.

Methods, systems, and computer storage media are provided for enabling management of a patient's blood when the patient has a scheduled elective procedure. Blood test results are received for the patient and are recorded in the patient's electronic medical record (EMR). It is determined that the elective procedure is associated with a high risk of blood loss. Based on the blood test results, it is determined that the patient requires blood treatment prior to the elective procedure. Blood treatment instructions are automatically determined and are displayed on the patient's EMR such that the clinician associated with the patient can review the instructions and determine if the patient will receive any or all of the recommended blood treatment prior to the elective procedure.

Decades of investigations were focused on finding “gold standard” for evaluation of plasma dilution and osmolality, blood loss evaluation and prediction of bleeding or transfusion induced changes in hematocrit and hemoglobin concentration. Addressing deficiencies of existing methods, the current invention created new combined mathematical-physiological model applicable to manually operated nomograms and software in medical monitors. The mathematical model HBS Trends is used in blood transfusion and infusion therapy nomogram—HBS Nomogram—which is based on blood hemoglobin concentration and hematocrit. It is also an easy and practical tool for recording and dynamical interpretation of plasma osmolality, blood hemoglobin concentration, hematocrit and mean corpuscular hemoglobin concentration. The HBS Nomogram is a practical system for organizing blood test results in a patient's medical records. It can be used alone or, in line with existing guidelines for infusion and transfusion therapy making them more practical, cost effective and time saving in decision making.

The invention provides a full-automatic blood sampling management system and method. According to the system and method, a number taking system, a main control system, a hospital LIS system, a labeling and code scanning system and a number calling system are associated to realize the interconnection of information, the medical personnel in each link can timely and correctly obtain the blood sampling item information of the patients, and the patients can conveniently know the blood sampling item information and moderately decide the approximate time of blood sampling according to the intentions, so that the problems of high manpower and material resource consumption, high operation error rate and low blood sampling process operation efficiency in the blood sampling management processes in hospitals can be solved, convenience is brought to the medical personnel or the patients to query the blood sampling item information, and the management for the blood sampling process, the blood sampling progress and the filing and query aiming at the blood test results of the patients in later period are facilitated.

The invention provides an intelligent full-automatic blood sampling management system and a control method thereof. According to the system and the control method, a number taking system, a main control system, a hospital LIS system, a labeling and code scanning system and a number calling system are associated to realize the interconnection of information, the medical personnel in each link can timely and correctly obtain the blood sampling item information of the patients, and the patients can conveniently know the blood sampling item information and moderately decide the approximate time of blood sampling according to the intentions, so that the problems of high manpower and material resource consumption, high operation error rate and low blood sampling process operation efficiency in the blood sampling management processes in hospitals can be solved, convenience is brought to the medical personnel or the patients to query the blood sampling item information, and the management for the blood sampling process, the blood sampling progress and the filing and query aiming at the blood test results of the patients in later period are facilitated.

A method of evaluating gastrointestinal cancer risk. The method comprises generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a gastrointestinal cancer risk of the target individual by classifying the set of features using the at least one classifier.

The present invention relates to methods and systems for providing an animal with a nutraceutical program that is specifically tailored to address the deficiencies and/or needs of the particular animal. Blood is drawn from the animal and analyzed at a lab to obtain blood test results. The blood test results are scored to obtain at least one blood test score for at least one corresponding blood parameter. If the at least one blood test score falls within a normal range but outside of an optimal range, one or more nutraceuticals needed to bring the animal within the optimal range for the at least one corresponding blood parameter are identified. A prescribed dosage amount is then calculated for at least one of the one or more identified nutraceuticals for the animal. The calculation of the prescribed dosage amount is based on at least the blood test score for the corresponding blood parameter and a deviation of the blood test score from the optimal range.

The invention discloses an early warning system based on independent risk factor combinatory screening. In the system, an input module of the system is used for inputting personal basic information of a user to be detected, a selector module is used by the user to be detected, to select a blood test scheme to be carried out, a blood sampling device is used for collecting blood of the user to be detected, a blood tester is used for detecting type of the chosen blood test scheme for the collected blood of the user to be detected, a data processing module is used for receiving blood test results transmitted by the blood tester, comparing the blood test results with pre-stored reference data, and transmitting comparison results and conclusions to a results processing module after comparison is complete, and the results processing module is used for processing the received comparison results and conclusions, and transmitting the processed results to a results output module for displaying. The system and method carry out detection in a most convenient and feasible manner, attack rate of serious diseases and death rate are decreased, and the cost is low.

The invention relates to a vacuum blood collection tube, and belongs to the technical field of medical equipment. According to the technical scheme, the vacuum blood collection tube comprises a vacuum tube body, a sealing plug used for sealing the vacuum tube body, and a cap used for fixing the sealing plug, a detachable damping baffle is arranged on the upper portion in the vacuum tube body to divide the tube body into the upper portion and the lower portion, a diversion port is formed in the detachable damping baffle, a spiral guiding channel is annularly formed in the inner wall of the tube body, and a label bag used for accommodating labels is arranged on the outer wall of the vacuum tube body. The vacuum blood collection tube has the advantages of being reasonable in structure, good in using effect, and capable of reducing the probability of hemolysis, thereby guaranteeing the reliability of blood test result data.

A method of evaluating lung cancer risk by generating a set of features comprising a plurality of current blood test results from a blood collected from a target individual, providing at least one classifier generated according to an analysis of a plurality of respective historical blood test results of each of another of a plurality of sampled individuals, and evaluating, using a processor, a lung cancer risk of said target individual by classifying said set of features using said at least one classifier. Each of said plurality of historical and current blood test results comprises results of one or more selected blood tests such as white blood cells blood test results, biochemistry test results, platelets blood test results including at least one of platelets count and mean platelet volume (MPV) and/or a combination of smoking history and red cell test results.

Disclosed are a method and a system using user personal, CBC, CMP and Lipid Panel data to detect a user acute myocardial infarction (AMI) risk and help user monitor AMI risk. Most AMI risk screening and diagnosis are related with the markers, video, image data, etc. although past researches have shown that serum albumin, RBC, MCV, MPV and PDW are all significantly correlated with AMI risk, use of the blood test results of CBC, CMP and Lipid Panel data to detect and monitor AMI risk has never been reported. Traditionally, AMI risk detecting and monitoring have been managed by doctors and hospitals and a user is unable to do it by himself or herself. The purpose of this invention is to provide an intelligent AMI risk detecting and monitoring system enabling users to detect and monitor AMI risk.

A pet blood tester includes a reader configured to read identification information of a pet from a tag; an analyzer configured to analyze blood of the pet to acquire information on the blood; a storage; a controller configured to receive stored body information of the pet corresponding to the identification information from at least one of an external device and the storage if the stored body information of the pet corresponding to the identification information is stored in at least one of the external device and the storage; and an inputter configured to receive input body information of the pet from a user if the body information of the pet corresponding to the identification information is not stored in at least one of the external device and the storage, wherein the controller is further configured to provide a blood test result and diagnosis information for the pet, based on the information on the blood, and the stored body information of the pet or the input body information on the blood.

The present disclosure relates to alternative methods of conducting standard blood chemistry tests, the methods typically comprising: extracting an RNA from a blood sample, determining a mRNA level of a predictive gene in the blood sample, and converting the mRNA level of the predictive gene into the blood test result of the target blood component. The present disclosure also relates to blood test for performing the proxy methods. The blood test includes a plasmid with at least an exon of a predictive gene, a reagent for detecting a mRNA level of the predictive gene, and a reagent for detecting a mRNA level of a housekeeping gene.

The invention discloses a dual-protection vacuum blood collection tube, which comprises a tube body, an inner liner tube and a seal ring, the inner liner tube is contained in the tube body, the orifice brim of the inner liner tube is wrapped by the seal ring, moreover, the inner liner tube is elastically fastened on the inner wall of the tube body by the seal ring, a PP (polypropylene) test tube is adopted as the inner liner tube, a plastic tube is adopted as the tube body, and furthermore, the upper end of the tube body is provided with a protective gas layer. The dual-protection vacuum blood collection tube is integrated with the non-fragility of the single PET (polyethylene terephthalate) plastic tube and the waterproofness of the PP test tube, and utilizes the protective gas layer to isolate a blood sample from contacting with the air, thus ensuring the accuracy of a blood test result, the entire structure is simple, and the practicability is high.

The invention relates to the technical field of medical devices, in particular to a blood test chip and a manufacture method thereof. The blood test chip comprises a carrier substrate, a conductive base layer arranged on the carrier substrate, and an insulating adhesive layer covering the conductive base layer, wherein a probe through hole is arranged on the insulating adhesive layer, the probe through hole is provided with a nano-metal probe protruding from the surface of the insulating adhesive layer, the nano-metal probe comprises a metal probe body and spinous protrusions on the surface of the metal probe body, antibody molecules detecting pathogens are adhered to the spinous protrusions and surroundings, the antibody molecules are at least one kind of DNA molecules, RNA molecules and immobilized enzyme molecules. Compared with the prior art, the blood test chip disclosed by the invention can give a blood test result within a few minutes or even few seconds, so that a user can know the health condition in time so as to carry out the timely disease prevention or treatment, and compared a conventional blood test in a hospital, the blood test chip greatly reduces the test cost, and makes blood test more convenient and more efficient.